|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/554 | |
| A61P 3/10 | |||
| A61P 3/04 | |||
| A61P 29/00 | |||
| A61K 9/00 | |||
| A61K 31/4985 | |||
| A61K 45/06 | |||
| A61K 9/02 | |||
| A61K 9/28 | |||
| A61K 31/155 | |||
| A61K 31/16 | |||
| A61K 31/18 | |||
| A61K 31/19 | |||
| A61K 31/191 | |||
| A61K 31/216 | |||
| A61K 31/38 | |||
| A61K 31/40 | |||
| A61K 31/42 | |||
| A61K 31/452 | |||
| A61K 31/454 | |||
| A61K 31/495 |
| (11) | Number of the document | 2575821 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11787464.4 |
| Date of filing the European patent application | 2011-05-26 | |
| (97) | Date of publication of the European application | 2013-04-10 |
| (45) | Date of publication and mention of the grant of the patent | 2015-08-12 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2011/038251 |
| Date | 2011-05-26 |
| (87) | Number | WO 2011/150286 |
| Date | 2011-12-01 |
| (30) | Number | Date | Country code |
| 348666 P | 2010-05-26 | US | |
| 348669 P | 2010-05-26 | US |
| (72) |
GEDULIN, Bronislava, US
YOUNG, Andrew, A., US
GREENE, Howard, E., US
|
| (73) |
Satiogen Pharmaceuticals, Inc.,
12555 High Bluff Drive, Suite 175, San Diego, CA 92130,
US
|
| (54) | BILE ACID RECYCLING INHIBITORS AND SATIOGENS FOR TREATMENT OF DIABETES, OBESITY, AND INFLAMMATORY GASTROINTESTINAL CONDITIONS |
| BILE ACID RECYCLING INHIBITORS AND SATIOGENS FOR TREATMENT OF DIABETES, OBESITY, AND INFLAMMATORY GASTROINTESTINAL CONDITIONS |